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In neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS), 
quality of life (QOL) – a patient’s ability and desire to lead a fulfilling life – is an important 
measure to determine disease evolution and treatment plan options. A comprehensive QOL 
assessment, however is challenging to gather in a clinical setting and relies on survey 
results convoluted with bias. Current research of QOL metrics in ALS are inadequate and 
limited to small, cross-sectional studies relying often on depression as the sole measure of 
QOL. This study proposes a new metric for QOL analysis gathered from qualitative 
physician remarks on patient mood in the clinical setting, referred to as clinic impression 
of mood (CIM). A meta-analysis of fifty-one factors gathered from over a thousand ALS 
patients who have visited the Emory ALS Center was performed to analyze the validity of 
CIM as a QOL measure. These factors are compared against CIM and depression scorings 
based on the revised clinical Assessment of Depression Index (ADI-12).  A chi-square test 
was used to compare binary factors and a linear regression model was used for continuous 
metric analysis. The results of this study demonstrate a strong relationship between CIM 
and survival duration. Further research into the relationship between CIM, depression, 
physical health, and survival will allow for more accurate disease progression predictions 







Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that 
currently has no cure. ALS is characterized by the progressive decline in muscle strength 
and control resulting in spasticity, paralysis, and ultimately complete respiratory failure. 
Disease progression is rapid providing most with life expectancy of 2-5 years after onset. 
Despite this bleak prognosis, arguments exist that quality of life (QOL), a measurement of 
an individual’s perceived happiness, does not diminish with disease progression meaning 
that as a person’s health declines, they retain a positive outlook on life.   
QOL is an important measure for clinical understanding of the psychological effects 
of ALS. The findings of past studies have disagreed as to whether or not there is a 
correlation between physical decline and a decreased QOL. Miglioretti et al suggests that 
quality of life (QOL) and mental function are independent factors (Miglioretti et al., 2008). 
His conclusion states that the Common Sense Model holds for ALS patients. This means 
that QOL is codependent on physical function and illness progression. In particular, this 
study shows, respiratory function and QOL appear to be most closely related. Robbins and 
Simmons disagree with Miglioretti arguing that QOL is not related to physical decline 
(Robbins et al., 2001; Simmons et al., 2000; Simmons, 2015).  
A thorough investigation of QOL factors and their relationships to physical and 
mental decline, is needed to improve clinical management and to better assess the impact 
of non-curative interventions. This research is imperative to the decision-making processes 
and affects choices like selecting treatment options. For example, if it can be shown that 
using specific non-invasive breathing therapies, such as bi-level positive airway pressure 
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(bi-pap), correlates with a higher QOL, patients might be more likely to use said options. 
Ultimately, patients need to properly understand the risks and rewards treatment options, 
etiological or palliative, offer for their projected QOL. Understanding these factors could 
also play a role in clinical treatment of ALS. Alternatively, if it can be shown that there is 
insufficient QOL data being collected in ALS clinics, it could allow for a push to include 
comprehensive surveys in annual treatment. Finally, these QOL factors play a key role in 
insurance coverage decisions and deeper research in this field could allow for key changes 
to improve patient treatment and intervention access. 
Disagreements among individual studies that have examined ALS QOL call for a 
more comprehensive assessment of QOL to assess existing and generate new hypotheses.  
To this end, this project utilizes a meta-analysis to examine QOL factors, including metrics 
of QOL and correlations of QOL with disease outcomes. A mass binary factor assessment 
can provide evidence for correlations between physical and mental health and the overall 
quality of life that ALS patients experience. Understanding these connections is key for 





 ALS is an incurable and aggressive neuromuscular disease that affects an estimated 
20,000 to 30,000 people in the United States, with over 6,000 new diagnoses per year 
(Malik et al., 2014). The general life expectancy from the time of diagnosis is 
approximately two to five years. While researching potential cures for ALS is important 
for long term eradication of the disease, these efforts will not aid patients who are currently 
battling ALS or who will receive their diagnosis before a cure can be found. For these 
people, quality of life (QOL) research has a more immediate benefit. QOL research centers 
on relationships between physical, mental, and social wellbeing and the overall satisfaction 
of persons affected by ALS. This research however is limited and varies widely across the 
field. Researchers have failed to agree on the relationships between ALS progression and 
factors such as physical ability, mental stability, and emotional or spiritual connectedness. 
Robbins, for example, argues that QOL is independent of physical health. Robbins’ 
study ventures outside of physical health correlations in quality of life (QOL) of ALS 
patients (Robbins et al., 2001). He also considers non-medical factors such as how religious 
or spiritual beliefs are altered by disease progression. Several QOL scales are used 
throughout this study including the McGill Quality of Life questionnaire (MQOL), 
Sickness Impact Profile (SIP), ALS Functional Rating Scale (ALSFRS), and the Idler 
Index of Religiosity (IIR). These four rating scales were used to perform two-way repeated 
measures multivariate analysis of variance tests. The general conclusion of this study is 
that QOL in ALS is independent of physical function. However spiritual, religious, and 
psychological factors varied based on physical abilities and progression. 
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Simmons hoped to show similar results as Robbins in regards to physical capabilities and 
QOL (Simmons et al., 2000). Simmons’ focused on the usability McGill Quality of Life 
questionnaire (MQOL) for the assessment of mental health. This rating scale has been 
validated in studies involving HIV and cancer patients, but is not used in ALS clinics. 
Contrary to Robbins, Simmons’ results were inconclusive, between physical decline and 
QOL. He did however validate the MQOL as a useful tool in ALS progression mapping. 
Miglioretti suggests that QOL and mental function are independent factors. His 
conclusion stands that the Common Sense Model holds for ALS patients (Miglioretti et al., 
2008). This means that QOL is codependent on physical function and illness progression. 
It is noteworthy that respiratory function and QOL appear to be most closely related based 
on the results of his study. By considering mood and life quality as independent, Miglioretti 
is able to gain differing results than the previously outlined studies. 
Pizzimenti also followed this thinking and found more concrete results arguing that 
depression and pain are closely related to QOL (Pizzimenti et al., 2013). An increase in 
pain correlated to a significant decrease in QOL as did an increase in depression. Pizzimenti 
argues that these two factors should be closely monitored by doctors and taken into 
consideration when prescribing medications. Lou agree with Pizzimenti’s finding about 
depression and includes that fatigue is also associated with a decline in QOL (Jau-Shin 
Lou, 2003). 
Lo Coco and Gauthier demonstrate a unique cross sectional study involving patients 
with ALS as well as their primary caregivers (Gauthier et al., 2007; Lo Coco et al., 2005). 
This allows for a unique perspective of the QOL of caregivers which surprisingly doesn’t 
follow the predicted progression. Lo Coco’s study indicates that caregivers reporting the 
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lowest QOL are not the same caregivers responsible for the most physically impaired 
patients. The study did indicate however that the patients QOL decreases with decreased 
physical function. Both of these studies provide great insights into the QOL of entire family 
units when someone is suffering from ALS. It is of note that Lo Coco’s study agrees with 
Miglioretti in that QOL and physical health have some correlations, thus refuting Robbins 
and Simmons (Robbins et al., 2001; Simmons et al., 2000). Gauthier however demonstrated 
that patient QOL was not related to physical health and rather only caregiver QOL 
depended on physical health factors. 
This disagreement among former studies gives rise to concern and can be 
misleading to patients researching their diagnosis. The primary issues with these studies 
are their sample sizes and data collection methods. Most ALS QOL studies are limited to 
extremely small groups of patients who are monitored using multiple complex QOL 
surveys taken on a regular basis. These QOL surveys are not currently in use at ALS clinics 
around the country. Most ALS patients never see one of these surveys and, if they do, the 
data is not passed from the clinic to researchers for analysis, making these surveys rather 
useless for clinical QOL tracking. 
A meta-analysis of clinical informatics could provide insight into the relationships 
between mental and physical decline and QOL in ALS. By analyzing measurable factors 
of physical health and interpreting doctor notes on mood and sleeping habits, an analysis 
of QOL can be performed from a different perspective than the perspective of the surveys 
typically used in these small studies. A meta-analysis will also allow for an exponentially 
larger sample size for data analysis which could allow for a more concrete conclusion. 
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An argument may be sustained that using clinical notes and medication usage rather 
than QOL surveys could weaken the integrity of the data. However, this is the best measure 
available from ALS clinics around the country. If the conclusion of this study finds that 
this clinic data is insufficient for analysis of QOL, it would demonstrate the need for stricter 
standardization of QOL surveys in clinical settings. Several studies have been performed 
over the course of decades that demonstrate the need for more compact QOL surveys in 
clinical settings (McGuire et al., 1997; Simmons et al., 2000; Simmons et al., 2006). 
Having a detailed understanding of patient and doctor perceived quality of life is 
imperative for ALS treatment plans and progression tracking as has been shown by Chio 
(Chio et al., 2004). They demonstrated that the health factors gathered in the clinical setting 
are not adequate for determining QOL and that measures that can be captured by various 
surveys need to be obtained to form an effective QOL study.  Patients need a clear 
understanding of how certain treatment decisions and physiological factors could impact 
their projected QOL. Current studies are not sufficient to aid in these decisions, leaving 
room in this field for a detailed meta-analysis of clinical factors. 
The current study utilizes a comprehensive binary collection of de-identified 
patient data from the Emory ALS Center in Atlanta, Georgia. Statistical correlations 
between physical health factors and QOL factors are analyzed in order to draw a more 
thorough conclusion than the aforementioned studies. The goal is to use a far more 
expansive sample size and easily measurable clinical health factors to conclude if 







3.1 Data Translation 
This study aims to define the relationships between physical health, mental health, 
and survival duration in ALS. To achieve this, data from patient appointments at the Emory 
ALS Center was transcribed into a relational database using the lab’s published biocuration 
protocol (Mitchell, 2015 J Undergrad Neurosci Educ), which includes independent quality 
control assessment to insure >98.8% transcription accuracy. All patient data for the present 
study was de-identified and anonymized. Forty-seven of the physical health and mental 
health indicators were translated from text-based physician charts into binary values. The 
remaining six physical health factors were numerical measure taken from the charts. These 
factors are defined in Table 1.  
Each physical health indicator is additionally categorized based on the specific field 
it encompasses. For example, forced vital capacity (FVC) is further categorized as a 
respiratory health indicator as it is the measure of the amount of air that can be forced out 
of the lungs during testing. 
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Table 1. Physical and mental health factors and categorizations 
 
Factor Data Type Category  
Forced vital capacity (FVC) Continuous  Respiratory 
Percent predict Continuous Respiratory 
Negative inspiratory force (NIF) Continuous Respiratory 
Oxygen saturation Continuous Respiratory 
ALSFRS-r respiratory Continuous Respiratory 
General pain present Binary Pain 
Level of disability Binary Disability 
ALSFRS-R Binary Disability 
Paraplegia  Binary Disability 
Quadriplegia  Binary Disability 
Hemiparesis Binary Disability 
Head drop Binary Muscle control 
Jaw jerk Binary Muscle control 
Toe walk Binary Muscle control 
Atrophy Binary Muscle control 
Moderate to severe atrophy  Binary Muscle control 
Fasciculation Binary Muscle control 
Atrophy Binary Muscle control 
Moderate to severe atrophy Binary Muscle control 
Swallowing problems Binary Oral muscle control 
Moderate to severe swallowing problems Binary Oral muscle control 
Drooling  Binary Oral muscle control 
Moderate to severe drooling Binary Oral muscle control 
Tongue atrophy Binary Oral muscle control 
Moderate to severe tongue atrophy Binary Oral muscle control 
Tongue fasciculation Binary Oral muscle control 
Dysarthria  Binary Vocal control 
Moderate to severe dysarthria Binary Vocal control 
Dysphasia  Binary Vocal control 
Moderate to severe dysphasia Binary Vocal control 
PEG tube placed Binary Gastrointestinal 
PEG tube nutrition use Binary Gastrointestinal 
PEG tube as main source of nutrition Binary Gastrointestinal 
Assistive device Binary Therapy 
Cough assist use Binary Therapy 
Suction use Binary Therapy 
Bi-pap usage Binary Therapy 
Antidepressant usage Binary Medication and Depression 
Drooling medication usage  Binary Medication and Oral muscle control 
Non-opioid pain medication usage Binary Medication and Pain 
Opioid pain medication usage Binary Medication and Pain 
NSAID medication usage Binary Medication and Pain 
Sleeping medication usage Binary Medication and Sleeping problems 
Muscle related medication usage Binary Medication and Muscle control 
Accompaniment to appointment Binary Lifestyle 
Family support Binary Lifestyle 
Hospice care  Binary Lifestyle 
Issues in home reported Binary Lifestyle 
Reported change in behavior Binary Lifestyle 
Sleeping problems reported Binary Sleeping problems 
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These factors were compared against two indicators of patient mental health: 
tertiary clinic impression of mood and depression. Clinic impression of mood is patient 
mood as recorded by a physician during a visit to the Emory ALS Center. Depression was 
measured using the revised, clinical assessment of depression index (ADI-12). Several 
therapy factors were considered as well, including bi-pap usage, antidepressant usage, and 
pain medication usage. 
In addition to comparing clinic impression of mood and depression against the 
factors listed in Table 1, duration of disease was compared from three different times to all 
previously mentioned factors. The three times analyzed include duration from diagnosis, 
duration from first appointment, and duration from symptom onset. The goal of this 
analysis was to determine if any of the fifty factors or depression are strongly correlated 
with duration of survival in ALS.  
The foremost anticipated correlation is between respiratory ability and depression. 
However, this study also aims to show relationships between mental health and 
antidepressant usage, pain medication usage, and muscle control loss. In addition to the 
overall aim of this study, the binary data generated could be used to perform several future 
studies. Correlations between the prevalence of any number of physical health indicators 
and participation in therapeutic interventions could be analyzed using this data. 
 
3.2 Clinic Impression of Mood Metric Development 
The newly developed measure of clinic impression of mood was derived from 
patient electronic health records from the Emory ALS Center. Qualitative physician notes 
relating to mood changes or general mood observations were translated into a binary 
measure herein referred to as clinic impression of mood (CIM). Patients were assigned a 
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zero for CIM at a given appointment if records of their mood indicated a “positive” or 
“neutral” mood. Patients were alternatively assigned a one for CIM if their mood was 
disturbed negatively. Each patient was evaluated on an individual basis throughout their 
appointment history. Consideration was given to their baseline mood at their first 
appointment and their mood changes were tracked from the first to their last appointment 
at the clinic. If there were no notes provided on mood at an appointment, the appointment 
was excluded.  
The database utilized in this study included categories for “Mood”, explicitly, as 
well as a category for “Other Visit Information”. Both categories were probed using 
specific keyword searches included in Table 2 below. If these categories were left blank 
or did not contain relevant information, a CIM score was not assigned for the 




Table 2. Keyword searches and corresponding clinic impression of mood (CIM) 
score determinations 
 






























* Requires probing of mood at previous appointment 
** Requires probing patient record mention of pseudobulbar affect (PBA), if 
confirmed, then crying or laughing is not considered as an indicator of mood  
 
3.3 Patient Inclusion and Exclusion Criteria 
Patients must have visited the Emory ALS Center at least once to have completed 
a preliminary appointment. Patients who were diagnosed with any disease other than ALS 
were excluded. Additionally, if a clear determination about factor application to a specific 
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appointment could not be determined, no data was entered for said factor on that 
appointment. The sample size varies between groups being analyzed but must be over 20 
appointments to be considered in this study. A total of 1,258 patients were included in the 
binary data generation, although not every patient was considered in every factor analysis. 
If the patient did not have a value for a factor area in an appointment, the factor was not 
considered for that appointment. Hence the variance in group sample sizes. 
 
3.4 Statistical Methods 
Statistical analysis was performed in Matlab. A chi-square test was used to compare 
two factors against each other to determine goodness of fit if both factors included 
exclusively binary data. A generalized linear model (GLM) was used for the continuous 
metric comparisons. A significant p-value was accepted as p < 0.05 and a confidence 





4.1 Clinic Impression of Mood (CIM) shows strong correlations to physical health 
Of the fifty categories analyzed, twelve were shown to be good predictors of clinic 
impression of mood (Table 2). In particular, clinic impression of mood (CIM) showed a 
high level of correlated decline with decreased respiratory function, as measured by percent 
predict and forced vital capacity (FVC). High level correlations are also present between 
CIM and some factors of muscle control, general pain, and cough assist usage. Lower level 
correlations with CIM exist with bi-pap usage, some additional muscle control factors, 
family support, and ALSFRS-R scores.  
Table 3. Clinic impression of mood significant factors 
 
 
Factor Sample size p-value 
Cough assist** 1,484 0.000622 
Bi-pap usage** 1,979 0.000012 
Jaw jerk** 2,112 0.000183 
Toe walk* 142 0.017957 
Swallowing problems* 840 0.014395 
Moderate to severe swallowing problems* 200 0.002729 
Drooling** 2,702 0.000745 
General pain** 671 0.000518 
Family support* 4,175 0.041075 
ALSFRS-R* 848 0.041246 
Percent predict** 1,300 0.000977 
Forced vital capacity (FVC)** 1,272 0.0000091 
Table 2 shows significant factors compared to clinic impression of mood with their 
respective p-values and the number of appointments analyzed for each category. 
*denotes 0.05 > p-value > 0.001, ** denotes p-value < 0.001; CI 95% 
 
To determine how these significant factors impact clinic impression of mood, 
bivariate fit plots were produced for each factor (Figure 1). The sloping direction of the 
line of best fit can be used to determine the correlational relationship between the factor 
and clinic impression of mood.  
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Figure 1. Bivariate fit of clinic impression of mood by significant factors. (A-G) 
Binary data for significant variables fit to CIM data using a logistical regression. (H-J) 





4.2 Depression shows few correlations to physical health due to limited sample size  
In order to compare the ADI-12 data to the fifty factors, three data sets were formed. 
Two binary sets of data were developed from the ADI total scores. The first group is 
categorized as depressed which includes all appointments where the patient scored a 23 or 
higher on the ADI-12 assessment (Hammer et al., 2008). The second group is categorized 
as majorly depressed and includes patients who scored a 30 or higher on the ADI-12 
assessment. The final group contains the raw ADI-12 scores.   
In the depression group, only the ALSFRS-R respiratory category was identified as 
a good predictor of depression. In the major depression group, the only statistically 
significant factor was clinic impression of mood. Finally, when comparing the raw ADI-
12 scores to all fifty factors, only muscle related medications, was shown to be related to 
ADI-12 scores.  
 
Figure 2. Bivariate fit of depression by ALSFRS-R respiratory scores 
Continuous data for ALSFRS-R Respiratory sub-scores fit to Depression data using a 




Figure 3. Bivariate fit of major depression by clinic impression of mood 
Binary data for Clinic Impression of Mood (CIM) fit to Major Depression data using a 
logistical regression. p-value < 0.05; 95% CI.  
 
 
Figure 4. Bivariate fit of ADI-12 scores by muscle related medications 
Binary data for Muscle Related Medication Usage fit to continuous ADI-12 scores 
using a logistical regression. p-value < 0.01; 95%  
 
4.3 Survival shows strong correlations to physical health and QOL factors  
 Duration of survival was collected in three groups for each patient: duration from 
onset, first visit, and diagnosis. Several predictive factors were identified in each survival 






Table 4. Duration from onset significant factors 
 
Factor  
Moderate to severe disability** 
Cough assist**  
Bi-pap use** 
Moderate to severe atrophy*  
Fasciculations present** 
Jaw jerk present * 
Swallowing problems** 
Moderate to severe swallowing problems*  
Drooling** 
Moderate to severe drooling* 
Tongue atrophy* 
Dysarthria**  
Moderate to severe dysarthria**  
Clinic impression of mood** 
General pain** 
Not accompanied to appointment**  
No family reported* 
No friend support* 
ALSFRS-R** 
Forced vital capacity (FVC)** 
ALSFRS-r respiratory*  
*denotes 0.05 > p-value > 0.001, ** denotes p-value < 0.001 
 
 Level of disability, respiratory therapies, CIM, pain, ALSFRS-R, and FVC all had 
a highly significant relationship when compared to survival from onset. Certain social 
factors were also predictive of survival: lack of accompaniment to an appointment at a 
high level and no friend support system or family identified at a low level. Finally, 
muscle control factors varied between low and high levels of significance. At a high level 
were reported fasciculation, swallowing problems, drooling, and dysarthria. At a low 
level were atrophy, jaw jerk, moderate to severe swallowing problems and drooling, and 






Table 5. Duration from first appointment significant factors 
 
Factor  




Moderate to severe atrophy**  
Fasciculations present** 
Head drop present* 
Jaw jerk present**  
Swallowing problems* 




Moderate to severe dysarthria**  
Clinic impression of mood** 
General pain** 
Sleeping problems*   
Not accompanied to appointment**  
No family reported* 
No friend support* 
ALSFRS-R** 
Percent predict**  
Forced vital capacity (FVC)** 
Negative inspiratory force (NIF)** 
ALSFRS-r respiratory**  
*denotes 0.05 > p-value > 0.01, ** denotes p-value < 0.001 
 
Level of disability, respiratory therapies, CIM, pain, ALSFRS-R, ALSFRS-r 
respiratory and all four respiratory measures had a highly significant relationship when 
compared to survival duration from first appointment at the Emory ALS Center. Certain 
social factors and reported sleeping problems were also predictive of survival at a low level 
of significance. Finally, muscle control factors varied between low and high levels of 
significance. At a high level were moderate to severe atrophy, dysarthria, reported 
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fasciculation, jaw jerk, tongue fasciculations. At a low level of significance were head drop, 
swallowing problems, and tongue atrophy.    
Table 6. Duration from diagnosis significant factors 
 
Factor  




Moderate to severe atrophy**  
Fasciculations present** 
Jaw jerk present*  
Toe walk* 
Swallowing problems** 
Moderate to severe swallowing problems* 
Moderate to severe drooling* 
Moderate to severe tongue atrophy* 
Tongue fasciculations** 
Dysarthria**  
Moderate to severe dysarthria**  
Moderate to severe dysphasia*  
Clinic impression of mood** 
General pain* 
Not accompanied to appointment**  
ALSFRS-R** 
Percent predict* 
Forced vital capacity (FVC)** 
Negative inspiratory force (NIF)** 
ALSFRS-r respiratory*  
*denotes 0.05 > p-value > 0.01, ** denotes p-value < 0.001 
 
Level of disability, respiratory therapies, CIM, ALSFRS-R, FVC, and NIF had a 
highly significant relationship when compared to survival duration from ALS diagnosis. 
Reported pain, ALSFRS-r respiratory, percent predict, and appointment accompaniment 
were also predictive of survival at a low level of significance. Again, muscle control factors 
varied between low and high levels of significance. At a high level were moderate to severe 
atrophy, swallowing problems, dysarthria, reported fasciculation, jaw jerk, tongue 
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fasciculations. At a low level of significance were moderate to severe swallowing 
problems, drooling, tongue atrophy, and dysphasia, in addition to jaw jerk, toe walk, 
swallowing problems, and tongue atrophy. It should be noted that while clinic impression 
of mood was determined to be a strong indicator of all three survival groups, neither the 
raw ADI-12 scores nor the binary depression categories from the ADI-12 data were found 





            The objective of this study is to analyze the ability of a newly proposed QOL metric, 
clinic impression of mood (CIM), to predict survival duration in ALS. Additionally, the 
ability for physical health to predict CIM will be explored. Together, these analyses will 
help determine the validity of CIM as an impactful QOL measure. Additionally, the 
relationship between physical health and survival will be discussed in light of the study’s 
findings. The final goal of this study is to answer whether QOL is dependent on physical 
health in ALS. The discussion of our findings will be presented in five sections that follow.   
 
5.1 ALSFRS-R Total scores are not significantly correlated with CIM or depression 
despite respiratory score correlation 
  ALSFRS scores have long been upheld in the ALS research community as a staple 
measure of disease progression and survival prediction (Cedarbaum et al., 1999). The 
ALSFRS-R total score was not a highly significant factor when compared with clinic 
impression of mood whereas percent predict and FVC respiratory measures were highly 
significant (Table 2, Figure 1). Additionally, ALSFRS-R total scores showed no 
significance in ADI-12 depression scoring categories.  
 Because ALSFRS scores are often used as a stand-in metric for survival, the 
analysis of ALSFRE-R total scores and respiratory sub-scores compared to survival 
duration was a key component of this work. While ALSFRS-R total scores showed high 
levels of significance, this is largely due to the linear regression model which is commonly 
employed in the analysis of ALSFRS scoring trends (Cedarbaum et al., 1999; Kimura et 
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al., 2006; Kollewe et al., 2008). Recent research on the validity of ALSFRS scores however 
has demonstrated concerns about the analysis of these scores using linear regression 
models and argues that these scores require a more robust analysis to avoid inaccurate 
interpretations of correlated variables (Franchignoni et al., 2013; Franchignoni et al., 2015; 
Mandrioli et al., 2015; Voustianiouk et al., 2008).  
 
5.2 Respiratory Ability and Muscle Control loss correlate with better mood outlook 
 Examining factors individually, it is shown that percent predict and FVC as 
measures of respiratory function are negatively associated with CIM. Therefore, as 
respiratory ability decreases, we see patient mood impression follows this decreasing trend. 
Patients who reported using respiratory therapies, namely cough assist and bi-pap, suffered 
less declined CIM levels. This is a positive indicator that intervention with such therapies 
could support an improved QOL (Bourke et al., 2001; Simmons, 2005). While ventilation 
data was not available for this study, the finding that lower respiratory function scores 
correlate with higher mood ratings aligns with the findings of several ventilation QOL 
studies in the ALS field (Gelinas et al., 1998; Kaub-Wittemer et al., 2003; Mustfa et al., 
2006).  
The presence of certain oral muscle control problems, namely jaw jerk, swallowing 
problems (any as well as moderate to severe), and drooling correlated with the absence of 
mood abnormalities. This indicates that the loss of these controls does not negatively 
impact mood, but rather correlates with a normal mood. This finding is in contrast to many 
studies that demonstrate that as these basic muscle controls are lost, risk of depression 
increases (Gauthier et al., 2007; Lo Coco et al., 2005).  
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Together, decreased FVC and percent predict and decreased muscle control are 
common as ALS progresses. Interpreting these results on a high level, they appear to 
indicate that later in disease progression, there is a lower instance of mood problems 
observed by clinicians. This demonstrates the similar findings as Kübler who showed a 
negative relationship between depression severity and disease duration (Kübler et al., 
2005). 
 
5.3 Tertiary Clinic Impression of Mood may be a strongly predictive metric to be 
used in addition to depression indices    
The lack of statistically significant results from the ADI-12 data is largely due to 
the limited sample size. This assessment was given to patients for a small window of time 
at the Emory ALS Center. Only 240 appointments out of 8,130 included completed ADI-
12 data. The number of appointments with corresponding physical health measures further 
slimmed down the sample size available for analysis. While no concrete conclusions could 
be drawn from the ADI-12 collected data, further research into this viability of data from 
this assessment should be conducted.    
An ongoing issue in the field of depression assessment is the use of surveys to 
retrieve information from patients. Recall bias has been shown to affect the depression 
statistics gained from surveying and must be considered when analyzing survey results 
(Coughlin, 1990; Kruijshaar et al., 2005; Patten, 2003). An easier metric to gather could be 
clinic impression of mood as interpreted by staff handling a patient in real time. Using this 
metric could alleviate the argument of recall bias and would be easier for physicians to 
gather during clinic visits. The goal of recording CIM is not necessarily to diagnose 
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depression, as physicians have proved less than successful at making this diagnosis from 
clinic visits, but rather to track variabilities in patient mood expression (Cepoiu et al., 2007; 
Cepoiu et al., 2008; Coventry et al., 2011; Mitchell et al., 2009; Rettew et al., 2009). CIM 
has shown viability in other epidemiological fields although caution has been given that a 
standard system of rating patient mood should be created (Balestrieri et al., 2002; Cepoiu 
et al., 2008; McDonald et al., 1999).  
Beyond future work on the ADI-12 depression relationship to physical health, more 
work should be conducted on the relationship between QOL and physical health as a whole. 
More regimented practices in ALS clinical setting could help researchers collect more 
usable data for this type of analysis. The type of records kept by the Emory ALS Center 
vary between appointments. Sometimes respiratory measures are recorded along with 
detailed notes on the patients’ general wellbeing and physical health as it is being impacted 
by ALS. Other times, there is very little data recorded about the patients’ health. More 
systematic practices in clinical settings could progress this field of research.  
Through this study, we have demonstrated the predictive power of clinic impression 
of mood (CIM) as a new QOL factor in ALS disease monitoring. Depression is a heavily 
relied on measure to describe mood incongruences in ALS patients however, we have 
demonstrated the need for a better metric for mood analysis and have provided an easily 
obtainable alternative to depression surveying in the clinical setting.   
 
5.4 As physical health declines so too does survival duration 
 As previously discussed, many studies rely on ALSFRS-R scores to measure 
progression and to predict survival (Atassi et al., 2014; Kimura et al., 2006; Zach et al., 
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2015). Our study however uses three distinct survival timelines based on the survival 
duration of patients from three different benchmarks: the first time they recall an onset 
symptom of ALS, their first appointment at the clinic, and their official diagnosis date. 
Our findings agree that ALSFRS-R scores are a strong indicator of survival durations in 
ALS.  
Respiratory factors, FVC and percent predict, were found to be strong predictors 
of survival duration. This finding agrees with many survival studies in the field on FVC’s 
predictive power which all agree that sustaining a higher FVC score correlates with 
prolonged survival (Baumann et al., 2010; Czaplinski et al., 2006; Stambler et al., 1998). 
Cedarbaum and Gordon argue that using FVC as a predictor of survival requires 
researchers to ignore complex factors at play such as the impacts of respiratory therapies 
such as non-invasive ventilation (NIV) and differences between therapies and procedure 
clinic to clinic (Cedarbaum and Stambler, 2001; Gordon et al., 2009). The findings of this 
study agree with many others that respiratory therapies such as bi-pap, a form of NIV, 
impact respiratory ability and therefore help prolong survival (Hardiman, 2011; Kleopa et 
al., 1999; Lechtzin et al., 2004; Lechtzin et al., 2007; Vrijsen et al., 2013; Vrijsen et al., 
2016). Hardiman’s research also takes into consideration how respiratory functioning 
impact QOL and he reports that intervening with NIV to preserve FVC correlates with an 
increased QOL through the prolonged survival duration. Our findings are in clear 
agreement.  
Our findings support that experiencing fasciculations is strongly correlated with a 
decreased duration of survival which is in agreement with other fasciculation studies in 
ALS (de Carvalho and Swash, 1998; Shimizu et al., 2014). There is little research on the 
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impact of muscle control loss on survival in ALS however. For this study, muscle control 
loss is indicated by reported or clinically observed atrophy of various muscles, increased 
drooling, and difficulty controlling oral muscles. Our findings support that as muscle 
control is reportedly decreased, survival duration also significantly decreases (Table 3-5).  
 
5.5 Positive mood outlook shows correlation with increased survival duration 
Our findings additionally suggest that lacking interpersonal relationships 
correlates with an increased survival duration. This may be due to the perception of 
burden on caregivers and friends throughout ALS progression (Chio et al., 2005; Galvin 
et al., 2016; Pagnini et al., 2010). Lacking these relationships may alleviate the stress 
associated with having loved ones watch or experience the deteriorating process of ALS 
on the body. This impact of interpersonal relationships on survival are largely speculative 
and social interaction is better analyzed in relation to QOL. While ALS patients often feel 
as though they are a burden on those around them, research shows that interpersonal 
relationships still assist in increasing patient QOL (Young and McNicoll, 1998). The 
directionality of this correlation was confirmed in our analysis however it was not found 
to be statistically significant.  
 Clinic impression of mood (CIM) was found to be strongly correlated with 
survival duration in ALS. Patients who exhibited mood disturbances during their clinic 
visits survived for a significantly shorter duration from onset, first appointment, and 
diagnosis. This key finding lends support to the argument that QOL is maintained 




5.6 Recommendations  
 Through this meta-analysis, a need has been demonstrated for further research in 
several key areas. First, further consideration should be given to the comparative value of 
binary CIM scores to continuous ADI-12 depression scores. A suitable sample size for 
this analysis could not be obtained through the Emory ALS Center database. A more 
robust statistical method should also be used to draw more concrete conclusion about the 
relationship between ALSFRS-R scores and survival duration. Finally, confirmation or 





Quality of life (QOL) has developed into a more highly researched aspect of ALS 
care in the last 20 years, however researchers have failed to agree on whether QOL is 
independent of a patient’s physical health. Our study has found that survival duration in 
ALS is impacted by several factors of physical health factors and by clinic impression of 
mood (CIM), which is a newly recommended measure for QOL. Furthermore, CIM was 
found to be predicted by several physical health factors. So, while the survival duration 
analysis seems to lend support to the notion that QOL is independent of physical health, 
the ability to predict CIM based on several physical health factors refutes this claim. This 
study agrees with the findings of Lo Coco and Miglioretti who claim that QOL is 
impacted by physical health. CIM has proved a strong predictive factor of survival 
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